MétaCan
Menu
Back to cohort
Record W3028180553 · doi:10.3389/fmed.2020.00280

Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials

2020· review· en· W3028180553 on OpenAlexaff
Guowei Li, Jie Zeng, Junxian Zhang, Lehana Thabane

Bibliographic record

VenueFrontiers in Medicine · 2020
Typereview
Languageen
FieldMedicine
TopicVenous Thromboembolism Diagnosis and Management
Canadian institutionsSt. Joseph’s Healthcare HamiltonMcMaster UniversityImpact
FundersGuangdong Medical Research Foundation
KeywordsMedicineApixabanRivaroxabanEdoxabanDabigatranRandomized controlled trialIntensive care medicineClinical trialInternal medicineWarfarinAtrial fibrillation

Abstract

fetched live from OpenAlex

Background: There is no direct comparison from clinical trials amongst the direct oral anticoagulants (DOACs) in patients with acute venous thromboembolism (VTE), leaving an evidence gap in decision-making regarding the choice of a DOAC. Methods: We performed a systematic review for an indirect comparison from randomized controlled trials (RCTs) for comparative effects amongst DOACs in the patients with acute VTE. Results: A total of 16 RCTs were included for analyses, among which 3 for dabigatran (n = 7,963 patients), 6 rivaroxaban (n = 17,935), 5 apixaban (n = 12,823), and 2 edoxaban (n = 9,286). There was no significant difference in risk of recurrent VTE (evidence quality: low) and major bleeding (evidence quality: very low) for treatment effects between the four DOACs. Albeit non-significantly, apixaban seemed to have a lowest risk of major bleeding while rivaroxaban had a smallest risk of VTE. Although in general all the included trials were comparable, data from the included trials indicated that the assumption of transitivity may be challenged. Further methodological research including simulation studies, using a net-benefit or benefit-harm approach, running ranking probability analysis, and developing decision aids with machine-learning may be a worthwhile endeavor to help with the choice of DOACs in patients with acute VTE. Conclusions: To conclude, based on results from the indirect comparison no significant difference in the efficacy and safety was found among the DOACs in patients with acute VTE. More evidence from direct comparative trials is needed to further inform the choice of DOACs in patients with acute VTE.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Direct model labels (unvalidated)

Per-model category and study-design labels from the labeling rounds. They are machine output, unvalidated, and the disagreement between models ships as data. No study design here is MEDLINE-validated yet.

Model armCategoriesStudy designConfidence
gemmano category
Domain: not available · Genre: Review
About the Canadian research system: no · About a Canadian topic: no
Meta-analysishigh
gptMeta-epidemiology (broad)
Domain: not available · Genre: Review
About the Canadian research system: no · About a Canadian topic: no
Meta-analysishigh
models splitAgreement compares identical category sets and study designs across arms.

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.169
metaresearch head score (Gemma)0.402
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.169
Threshold uncertainty score0.894

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1690.402
Meta-epidemiology (narrow)0.0040.002
Meta-epidemiology (broad)0.0180.033
Bibliometrics0.0090.007
Science and technology studies0.0010.004
Scholarly communication0.0070.006
Open science0.0030.003
Research integrity0.0050.005
Insufficient payload (model declined to judge)0.0110.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.114
GPT teacher head0.434
Teacher spread0.320 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Labeled directly by 2 models reading the full record.

Meta-epidemiology (broad)

The models disagree on parts of this classification; every voice is preserved in the section at the end of the page.

Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in MedicineSame topicVenous Thromboembolism Diagnosis and ManagementCategoryMeta-epidemiology (broad)French-language works237,207